Clinical Trials for Keymed Biosciences

Explore 34 clinical trials worldwide

Showing 1-34 of 34 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Keymed Biosciences

Clinical Trials (34)

NCT07175493
A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia
PHASE1/PHASE2Not yet recruiting
158 participants
Started: Oct 31, 2025 · Completed: Oct 31, 2028
4 conditions1 sponsor1 location
NCT07106372
A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis
PHASE3Not yet recruiting
240 participants
Started: Sep 30, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06830395
Study of CM313 in Subject With IgA Nephropathy
PHASE2Not yet recruiting
106 participants
Started: Sep 30, 2025 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT07175506
Study of CM559 in Healthy Subjects
PHASE1Recruiting
40 participants
Started: Sep 30, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT07181239
Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients
PHASE3Not yet recruiting
280 participants
Started: Sep 30, 2025 · Completed: Apr 30, 2030
1 condition1 sponsor1 location
NCT07166211
Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)
PHASE2Not yet recruiting
48 participants
Started: Sep 15, 2025 · Completed: Jan 14, 2027
1 condition1 sponsor1 location
NCT07011524
Study of CM512 Injection in Subjects With Moderate-to-severe Asthma
PHASE2Recruiting
200 participants
Started: Aug 19, 2025 · Completed: Jul 21, 2027
1 condition1 sponsor1 location
NCT07040072
Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC
PHASE1Not yet recruiting
10 participants
Started: Jun 30, 2025 · Completed: Jun 30, 2028
1 condition3 sponsors1 location
NCT07039578
Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis
PHASE2Recruiting
90 participants
Started: Jun 30, 2025 · Completed: Jul 31, 2029
1 condition1 sponsor2 locations
NCT06980142
A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
PHASE2Not yet recruiting
204 participants
Started: Jun 20, 2025 · Completed: Mar 17, 2028
1 condition1 sponsor0 locations
NCT06947980
Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
PHASE2Recruiting
200 participants
Started: Jun 19, 2025 · Completed: Nov 7, 2026
1 condition1 sponsor1 location
NCT07019779
Study of CM518D1 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Not yet recruiting
434 participants
Started: Jun 9, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06956196
Study of Stapokibatrt in Children Subjects With Atopic Dermatitis
PHASE3Not yet recruiting
240 participants
Started: May 31, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06930612
A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis (NEZHA-1)
PHASE2Not yet recruiting
120 participants
Started: May 16, 2025 · Completed: Sep 16, 2026
1 condition1 sponsor1 location
NCT06791824
Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia
PHASE1/PHASE2Not yet recruiting
125 participants
Started: Mar 31, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06792019
Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness
PHASE1/PHASE2Recruiting
110 participants
Started: Mar 25, 2025 · Completed: Nov 16, 2027
1 condition1 sponsor1 location
NCT06791772
Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)
PHASE2Not yet recruiting
150 participants
Started: Feb 28, 2025 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT06769555
BCMA/CD3 BiTE for RRAL or NDAL Amyloidosis With Insufficient Depth of Hematologic Response After Induction Therapy
NANot yet recruiting
20 participants
Started: Jan 1, 2025 · Completed: Aug 1, 2028
1 condition2 sponsors0 locations
NCT06745687
BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma
NANot yet recruiting
20 participants
Started: Dec 30, 2024 · Completed: Aug 1, 2028
1 condition2 sponsors1 location
NCT06594146
Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)
PHASE2Active, not recruiting
62 participants
Started: Nov 11, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06619613
A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease
PHASE1Recruiting
48 participants
Started: Nov 8, 2024 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT06525597
Study of Stapokibart Injection in Patients With Allergic Rhinitis
PHASE2Recruiting
120 participants
Started: Sep 30, 2024 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06495229
Study of CM310 in Adolescent Subjects With Atopic Dermatis
PHASE3Active, not recruiting
180 participants
Started: Aug 2, 2024 · Completed: Aug 30, 2026
1 condition1 sponsor1 location
NCT06372678
Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis
PHASE2Not yet recruiting
90 participants
Started: Jun 30, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06424470
Study on the Treatment of Prurigo Nodularis With Stapokibart Injection
PHASE3Active, not recruiting
200 participants
Started: Jun 25, 2024 · Completed: Jul 30, 2026
1 condition1 sponsor1 location
NCT06412185
Single Dose Escalation Study of CM383 in Healthy Volunteers
PHASE1Recruiting
56 participants
Started: May 28, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06171048
Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects
PHASE1Not yet recruiting
236 participants
Started: Apr 30, 2024 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT06171074
Study of CM310 in Subjects With Seasonal Allergic Rhinitis
PHASE2Not yet recruiting
100 participants
Started: Mar 30, 2024 · Completed: Mar 30, 2025
1 condition1 sponsor1 location
NCT06116565
A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis
PHASE2Not yet recruiting
300 participants
Started: Mar 30, 2024 · Completed: Mar 30, 2026
1 condition1 sponsor0 locations
NCT06285227
Study of CM313 in Healthy Subjects
PHASE1Recruiting
51 participants
Started: Mar 12, 2024 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT06126237
A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2Not yet recruiting
120 participants
Started: Feb 28, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor0 locations
NCT05775042
Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy
PHASE2Recruiting
70 participants
Started: May 8, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05299424
A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2Recruiting
48 participants
Started: Aug 9, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05263960
A Study of CM350 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
248 participants
Started: Apr 21, 2022 · Completed: Apr 30, 2027
1 condition1 sponsor2 locations